Vienna Parent Corporation, a newly formed special purpose entity (“Vienna Parent”) formed by Justin Christian, announced today that it has entered into a definitive agreement to acquire TSR, Inc. (“TSR”) (NASDAQ: TSRI). Under the terms of the agreement, Vienna Acquisition Corporation, an affiliate and wholly-owned subsidiary of Vienna Parent (“Vienna Sub”), will commence a tender offer to purchase all of the outstanding shares of TSR for $13.40 per share, representing an equity value of approximately $29 million. The total consideration payable to TSR’s shareholders represents a 73.8% premium to TSR’s closing price on May 14, 2024.

Joined John Deere supply base and chosen to deploy DriveMod Tuggers to Dubuque, IA operation.Renewed contract with US Continental, unveiling a study that found Cyngn's autonomous vehicles yielded 4x efficiency gain.Announced initial deployment with Rivian.Announced strategic partnership with RobotLAB, expanding the Cyngn Distributor Network.Aligned with Nvidia to power DriveMod's artificial intelligence.Attended MODEX with Motrec, premiering the DriveMod Tugger autonomous MT-160. Secured our 19th granted US patent.Launched our "auto-unhitch" feature, enabling DriveMod Tuggers to drop off carts without requiring any human intervention.MENLO PARK, Calif., May 16, 2024 /PRNewswire/ -- Cyngn Inc. (the "Company" or "Cyngn") (Nasdaq: CYN) today shared several commercial and technological accomplishments ...

AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, and designed for both commercial and government applications, is providing its business update for the three months ended March 31, 2024.

Omeros Corporation (Nasdaq: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders, today announced recent highlights and developments as well as financial results for the first quarter ended March 31, 2024, which include...